Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Community Health ; 2024 Apr 20.
Artigo em Inglês | MEDLINE | ID: mdl-38643316

RESUMO

Community-based health events provide an opportunity to increase knowledge, awareness, and screening for acute and chronic diseases among individuals living in a socioeconomically diverse community. Because there are limited reports of such events, here we describe our ten-year experience of annual men's health fairs. This retrospective study of the Michigan Institute of Urology Foundation evaluated Men's Health Events held in Detroit, Michigan, from 2012 to 2021. Over 10 years, 11,129 men were screened and > 100,000 screenings were performed. The majority of the attendees were African-American men (61%), had a college degree (67%) or a high school diploma (26%), and had an annual income of <$35K (47%) or $35-60 K (30%). From 2012 to 2021, participants who saw a doctor in the past year rose from 62 to 70%; the median age of men rose from 52 to 58; their median testosterone levels increased from 353 ng/dL to 412 ng/dL, and men with concerning prostate-specific antigen values (≥ 4 ng/mL) doubled from 5% to 10%. Among participants, 59% had cholesterol levels of < 200 mg/dL, 28% of 200-240 mg/dL, and 13% of > 240 mg/dL; 7% had glucose levels of < 70 mg/dL, 68% of 70-105 mg/dL, and 25% of > 105 mg/dL ; 24% had ≥ 140 mmHg systolic and 18% had ≥ 90 mmHg diastolic blood pressure. Our findings suggest that community health events are successful at attracting and screening diverse community members. Such events should emphasize screening of high-risk individuals for acute and chronic diseases and promote other health-related behaviors.

2.
Cardiovasc Diabetol ; 20(1): 140, 2021 07 10.
Artigo em Inglês | MEDLINE | ID: mdl-34246277

RESUMO

BACKGROUND: The pleiotropic effects of statins may reduce the severity of COVID-19 disease. This study aims to determine the association between inpatient statin use and severe disease outcomes among hospitalized COVID-19 patients, especially those with Diabetes Mellitus (DM). RESEARCH DESIGN AND METHODS: A retrospective cohort study on hospitalized patients with confirmed COVID-19 diagnosis. The primary outcome was mortality during hospitalization. Patients were classified into statin and non-statin groups based on the administration of statins during hospitalization. Analysis included multivariable regression analysis adjusting for confounders and propensity score matching to achieve a 1:1 balanced cohort. Subgroup analyses based on presence of DM were conducted. RESULTS: In the cohort of 922 patients, 413 had a history of DM. About 27.1% patients (n = 250) in the total cohort (TC) and 32.9% patients (n = 136) in DM cohort received inpatient statins. Atorvastatin (n = 205, 82%) was the most commonly prescribed statin medication in TC. On multivariable analysis in TC, inpatient statin group had reduced mortality compared to the non-statin group (OR, 0.61; 95% CI, 0.42-0.90; p = 0.01). DM modified this association between inpatient statins and mortality. Patients with DM who received inpatient statins had reduced mortality (OR, 0.35; 95% CI, 0.21-0.61; p < 0.001). However, no such association was noted among patients without DM (OR, 1.21; 95% CI, 0.67-2.17; p = 0.52). These results were further validated using propensity score matching. CONCLUSIONS: Inpatient statin use was associated with significant reduction in mortality among COVID-19 patients especially those with DM. These findings support the pursuit of randomized clinical trials and inpatient statin use appears safe among COVID-19 patients.


Assuntos
Tratamento Farmacológico da COVID-19 , COVID-19/mortalidade , Diabetes Mellitus/tratamento farmacológico , Diabetes Mellitus/mortalidade , Hospitalização/tendências , Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Idoso , COVID-19/diagnóstico , Estudos de Coortes , Diabetes Mellitus/diagnóstico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pontuação de Propensão , Estudos Retrospectivos , Resultado do Tratamento
3.
Ethn Dis ; 24(4): 431-7, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25417425

RESUMO

INTRODUCTION: Hypertension among African Americans is higher compared to Whites and has an early onset, greater severity, and is associated with more organ damage. We examined whether pharmaceutical treatment of hypertension among underserved African American elderly is consistent with the current treatment guidelines and whether treatment variations occur due to existing co-morbidities among the hypertensive. METHODS: Our study surveyed 400 African Americans, aged ≥ 65 years, recruited from 16 predominantly African American churches located in South Los Angeles. The study used face-to-face interviews which documented type, frequency, and dosage of all medications used by participants. Label information of each drug was recorded. RESULTS: Our data indicate: 1) 29% were on one anti-hypertensive medication; 60% were taking 2-3 medications; and 9% were on four classes of anti-hypertensive medication; 2) among the elderly taking a combination of two or more drugs, ACE or ARB was used 76% in combination of agents, diuretics 60%, calcium channel blockers 63%, and beta-blocker 61%; and 3) 26% of the elderly were taking ≥ 3 medications including a diuretic. CONCLUSIONS: Treatment of hypertension appears to be inconsistent with the prevailing treatment guidelines for nearly one-third of the aged African Americans. Further investigation is needed to determine why a significant number of individuals from this under-served population are not receiving care based on established clinical guidelines.


Assuntos
Anti-Hipertensivos/uso terapêutico , Negro ou Afro-Americano , Hipertensão/tratamento farmacológico , Hipertensão/etnologia , Populações Vulneráveis/etnologia , Idoso , Idoso de 80 Anos ou mais , Complicações do Diabetes/complicações , Complicações do Diabetes/etnologia , Complicações do Diabetes/terapia , Diuréticos/uso terapêutico , Quimioterapia Combinada , Feminino , Fidelidade a Diretrizes , Humanos , Hipertensão/complicações , Masculino , Guias de Prática Clínica como Assunto , Padrões de Prática Médica , Insuficiência Renal Crônica/complicações , Insuficiência Renal Crônica/etnologia , Insuficiência Renal Crônica/terapia , Fatores Socioeconômicos
4.
Cureus ; 14(9): e29081, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-36258953

RESUMO

Septic arthritis is a medical emergency that rarely occurs without direct trauma to a joint, compromise or trauma to the synovium, or internal hematogenous seeding from bacteremia. Infection of a single joint space is a cause for concern, and infection of multiple joints is even more rare and concerning. Human immunodeficiency virus (HIV) renders patients particularly susceptible to encapsulated bacteria as it compromises opsonization, humoral immunity, as well as neutrophil function. Neutrophils play an important role in preventing and fighting off infections of the synovium, and it is well documented that compromised neutrophil function can result in this peculiar infection. HIV is popularly acknowledged for its suppression of the lymphoid division of the immune system, particularly CD4 T-cells suppression. However, HIV's effects on myeloid cells are largely overlooked in medical academia, specifically with respect to neutrophil dysfunction. We will explore a case where compromised neutrophil function results in rare infiltration of Haemophilus influenzae resulting in polyarticular septic arthritis.

5.
Cureus ; 14(4): e24014, 2022 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-35547412

RESUMO

Antiphospholipid syndrome (APS) is a rare coagulopathic disorder diagnosed with a combination of clinical/imaging findings with specific antibody titer elevations over a period of 12 weeks. The following case report will discuss the unusual and challenging hospital course of a patient with extensive autosomal dominant polycystic kidney disease (ADPKD) being treated for a multi-drug resistant urinary tract infection (UTI). The patient later developed multiple deep vein thrombosis (DVT) and was found to have antiphospholipid syndrome. Warfarin, the anticoagulant of choice for antiphospholipid syndrome, has a higher likelihood of intracerebral hemorrhage than direct oral anticoagulants. This is particularly challenging since patients with autosomal dominant polycystic kidney disease have a higher propensity to develop intracranial aneurysms (ICA).

SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa